Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

EU or US and have no other ongoing safety concerns, such as a clinical hold on other ongoing studies. “Clinical trials regulation should be flexible and risk-proportionate so that the regulatory ...

Recent measures like the EU Clinical Trial Regulation (CTR), which came into effect at the start of 2023, have not been implemented quickly enough to counteract slow set-up times and lacklustre ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Coldiretti rallied 20,000 farmers to demand the EU assess cultivated meat like new drugs, citing concerns from scientists – ...

The landscape of clinical trials has undergone significant changes, as highlighted in the current Series of six papers published in The Lancet Global Health. The WHO guidance provides a comprehensive ...

The European Commission is considering changes to EU energy laws as part of its next package of proposals to cut the ...

Sen. Bill Hagerty has introduced the PROTECT USA Act to protect U.S. companies from the European Union’s Corporate Sustainability Due Diligence Directive, which imposes excessive ...